[HTML][HTML] Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature

F Cagnazzo, C Arquizan, I Derraz, C Dargazanli… - Journal of …, 2021 - Springer
… Higher levels of blood C-reactive protein, and higher d-dimer concentration [40] have be
reported in SARS-CoV-2 patients with acute cerebrovascular disease, underlining a …

[HTML][HTML] Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

JL Mas, C Arquizan, C Lamy, M Zuber… - … England Journal of …, 2001 - Mass Medical Soc
Background Patent foramen ovale and atrial septal aneurysm have been identified as potential
risk factors for stroke, but information about their effect on the risk of recurrent stroke is …

[HTML][HTML] Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke

…, H Hosseini, L Mechtouff, C Arquizan… - … England Journal of …, 2017 - Mass Medical Soc
Background Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have
been inconclusive. We investigated whether patients with cryptogenic stroke and …

[HTML][HTML] A randomized trial of intravenous alteplase before endovascular treatment for stroke

…, IR de Ridder, V Costalat, C Arquizan… - New England journal …, 2021 - Mass Medical Soc
Background The value of administering intravenous alteplase before endovascular treatment
(EVT) for acute ischemic stroke has not been studied extensively, particularly in non-Asian …

Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study

C Lamy, C Giannesini, M Zuber, C Arquizan, JF Meder… - Stroke, 2002 - Am Heart Assoc
Background and Purpose— Patent foramen ovale (PFO) has been identified as a potential
risk factor for stroke, but the mechanisms of PFO-associated stroke remain unsettled. The aim …

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial

…, JL Saver, J Gralla, A Alonso, C Arquizan… - The Lancet, 2022 - thelancet.com
Background Whether thrombectomy alone is equally as effective as intravenous alteplase
plus thrombectomy remains controversial. We aimed to determine whether thrombectomy …

Early and late seizures after cryptogenic ischemic stroke in young adults

C Lamy, V Domigo, F Semah, C Arquizan, D Trystram… - Neurology, 2003 - AAN Enterprises
Objectives: To assess the incidence and predictive factors of early and late seizures after
ischemic stroke in young adults. Methods: A total of 581 patients (aged 18 to 55 years) with …

Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: a prospective 50-patient single …

…, D Milhaud, C Héroum, PF Perrigault, C Arquizan… - Stroke, 2011 - Am Heart Assoc
Background and Purpose— Large vessel occlusion in ischemic stroke is associated with a
high degree of morbidity. When intravenous thrombolysis fails, mechanical thrombectomy can …

Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size

…, J Labreuche, B Lapergue, C Arquizan - … England Journal of …, 2024 - Mass Medical Soc
Background The use of thrombectomy in patients with acute stroke and a large infarct of
unrestricted size has not been well studied. Methods We assigned, in a 1:1 ratio, patients with …

Stent retrievers in acute ischemic stroke: complications and failures during the perioperative period

…, G Mercier, I Mourand, C Arquizan… - American Journal …, 2014 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Stent retriever–assisted thrombectomy promotes high
recanalization rates in acute ischemic stroke. Nevertheless, complications and failures occur in …